SpineGuard, Omnia Medical Obtain New U.S. Patent for Sacroiliac Joint Fusion Tech

SpineGuard and Omnia Medical have been awarded a U.S. patent for their Dynamic Surgical Guidance (DSG) technology, a radiation-free, real-time navigation solution designed to secure and streamline accurate spinal implant placement.

The recently allowed patent applications, applied jointly by SpineGuard and Omnia Medical, describe the use of the DSG tissue differentiating feedback technology for the precise positioning of sacroiliac fusion implants. The patents are the result of a co-development effort to offer the U.S. market a reliable, simple, and efficient procedural solution for treating sacroiliac joint degeneration and pain.

“The SpineGuard team is proud to collaborate with Omnia Medical to offer the best solution to patients and physicians in an already large and fast-growing market segment: the posterior sacroiliac joint fusion in the U.S.A.,” SpineGuard Co-Founder/Deputy CEO Stéphane Bette said. “This represents for our DSG technology a very promising application that should contribute more and more to increasing our top line and reaching our operational profitability goal.”

The sterile-delivered surgical kit that includes Omnia’s implants, instruments, biologics, as well as SpineGuard’s PsiFGuard guidance tool, is well-suited for light operative setups such as ambulatory centers or offices, according to the companies. Accelerating the U.S. commercial launch of the combined product offering—now backed by fully protected surgical technique intellectual property— marks a key milestone in the joint commercialization roadmap announced by the two companies early last year.

“This patent allowance further strengthens Omnia Medical’s leadership in posterior sacroiliac fusion and reflects the power of our collaboration with SpineGuard. Together, we’ve developed the only enabling technology specifically designed to identify the sacroiliac joint during posterior SI fusion procedures,” Omnia Medical Co-Founder/CEO Troy Schifano stated. “Innovation is what defines Omnia, and we will continue to protect the technologies we create in a market where innovation is too often met with imitation. Accurate implant placement is the prerequisite for a successful fusion, yet implant misplacement remains an ever-growing challenge in posterior SI fusion. SpineGuard’s DSG technology is a much-needed solution to that problem, and Omnia is proud to be the only company providing enabling technology specifically designed to objectively identify the sacroiliac joint before implant placement. If the implant isn’t in the right place, a successful fusion simply cannot occur.”

More than 15% of patients suffering from back pain are estimated to have a degenerative sacroiliac joint causing debilitating pain. The global market of sacroiliac joint fusion reached more than $800 million in 2021, and is projected to grow 16% to 20% annually through 2030 according to Mordor Intelligence. A new U.S. payment code implemented in January 2024 for posterior sacroiliac joint fusion surgery could accelerate this expected growth.

Since its foundation, SpineGuard has developed and maintained an IP portfolio that currently includes 11 patent families as well as three trademarks in Europe, the United States, China, and Japan.

Founded in 2009 in France and the United States by Bette and Pierre Jérôme, SpineGuard is deploying its proprietary radiation-free real-time sensing technology, DSG, to secure and streamline implant placement. The company designs, develops, and markets medical devices embedding its technology. More than 110,000 surgical procedures have been secured worldwide with DSG and 39 studies published in peer-reviewed scientific journals have demonstrated the technology’s multiple benefits to patients, surgeons, surgical staff, and hospitals. Building on these strong fundamentals and several strategic partnerships, SpineGuard is expanding the scope of its DSG technology to treat scoliosis through the anterior approach, sacroiliac joint fusion, dental implants, and innovations such as the smart pedicle screw, power drill, or surgical robotics. DSG was co-invented by Maurice Bourlion, Ph.D.; Ciaran Bolger, M.D., Ph.D.; and Alain Vanquaethem, biomedical engineer.

Founded in 2014 and headquartered in Morgantown, W.V., Omnia Medical is an orthopedic implant company developing spine and sacroiliac solutions. The company strives to deliver safe, reproducible surgical products that improve clinical outcomes while reducing operative time and overall healthcare costs. Omnia Medical offers various spine implants, including a proprietary line of interbodies featuring TiBrid osseointegrative surface technology, and is a recognized innovator in sacroiliac joint fusion.